Skip to content

Clinical trials

Phase 1/2 Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 1/2 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20095
20102
20111
20121
20141
20161
20182
20191
20202
20213
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status5
Recruiting4
Terminated4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Assistance Publique - Hôpitaux de Paris1
Bambino Gesù Hospital and Research Institute1
Chinese University of Hong Kong1
Corewell Health East1
Devalingam Mahalingam1
First Affiliated Hospital of Chengdu Medical College1
Hunter Holmes Mcguire Veteran Affairs Medical Center1
Jöri Pünchera1
Leiden University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis31
Liver Cirrhosis5
Liver Diseases4
Non-alcoholic Fatty Liver Disease4
Carcinoma, Hepatocellular3
End Stage Liver Disease3
Fatty Liver3
Hypertension, Portal3
Neoplasms3
Hepatic Encephalopathy2

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.